Harvard BioscienceHBIO 
$2.78-5.44%24h
-5.44%24h
Global rank20304
Market cap$118.67M
Change 7d-4.14%
YTD Performance-48.04%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Harvard Bioscience (HBIO)
As of November 2024, Harvard Bioscience has a market cap of $118.67M. This makes Harvard Bioscience the world's 20304th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Harvard Bioscience from 2001 to 2024
-
Value:-
Market cap history of Harvard Bioscience from 2001 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $201.17M | -11.92% |
| 2023 | $228.38M | 93.14% |
| 2022 | $118.25M | -60.71% |
| 2021 | $300.95M | 64.34% |
| 2020 | $183.13M | 40.66% |
| 2019 | $130.20M | -4.09% |
| 2018 | $135.75M | -3.64% |
| 2017 | $140.87M | 8.20% |
| 2016 | $130.20M | -12.10% |
| 2015 | $148.13M | -38.80% |
| 2014 | $242.04M | 20.64% |
| 2013 | $200.63M | 41.54% |
| 2012 | $141.75M | 13.18% |
| 2011 | $125.25M | -5.15% |
| 2010 | $132.05M | 14.29% |
| 2009 | $115.54M | 34.72% |
| 2008 | $85.76M | -42.14% |
| 2007 | $148.23M | -10.72% |
| 2006 | $166.03M | 15.28% |
| 2005 | $144.02M | -3.89% |
| 2004 | $149.85M | -47.98% |
| 2003 | $288.04M | 170.52% |
| 2002 | $106.48M | -66.90% |
| 2001 | $321.70M | - |
HBIO Market Cap Today is $118.67M -5.44% - 22 Nov 2024
View largest stocks by market cap 
